Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novagali cleared to begin U.S. phase III study of Nova-22007

April 30, 2007

CHMP to recommend that occult indication be deleted from Visudyne E.U. label

April 27, 2007

Enrollment ongoing in phase III study of Medidur for DME

April 27, 2007

Two phase II/III trials evaluate NT-501 in retinitis pigmentosa

April 20, 2007

FDA grants orphan drug status to ganciclovir for acute herpetic keratitis

April 19, 2007

Sirion raises financing to advance pipeline

April 13, 2007

Recent Asahi Kasei patent reports novel agents for treating glaucoma

April 12, 2007

Vekacia demonstrates efficacy in vernal keratoconjunctivitis phase III trial

April 11, 2007

MM-093 begins pilot study in autoimmune uveitis

April 11, 2007

LX-201 begins pivotal trials

April 10, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...